B12 Deficiency: Neurological Symptoms You Shouldn't Ignore

A 2026 case report published in Frontiers in Psychiatry describes a patient whose vitamin B12 deficiency went undetected for months — not because testing was unavailable, but because the symptoms looked exactly like a primary affective disorder. Mood disturbances, cognitive slowing, and behavioral changes led clinicians toward a psychiatric diagnosis first. Only later did imaging reveal subacute combined degeneration (SCD), a serious and potentially irreversible deterioration of the spinal cord caused by B12 insufficiency. The case illustrates a problem that runs deeper than simple oversight: the neurological face of B12 deficiency is genuinely complex and frequently misidentified in clinical practice.

Why B12 Deficiency Hides in Plain Sight

Vitamin B12 — cobalamin — plays a foundational role in the nervous system. It is essential for synthesizing myelin, the insulating sheath that allows nerve impulses to travel efficiently. It also participates in the conversion of homocysteine to methionine, a step critical for DNA synthesis and neuronal repair. When B12 levels fall, these processes slow or fail, and the damage accumulates silently over months before symptoms reach a threshold that triggers medical attention.

The insidious onset is one reason deficiency is underdiagnosed. Body stores can sustain normal function for two to five years after dietary intake drops significantly — meaning a person who eliminates all animal products may not develop clinical symptoms until years later. By that point, neurological damage may already be present and partially irreversible. Complicating matters further, standard serum B12 assays measure total circulating cobalamin, including biologically inactive forms, creating a grey zone where functional deficiency exists alongside a technically borderline-normal result.

The Full Spectrum of Neurological Symptoms

No two presentations look exactly alike, but a recognizable clinical pattern emerges across reported cases. The most common early neurological symptom is peripheral neuropathy: tingling, numbness, or a burning sensation in the hands and feet, typically beginning symmetrically in the distal limbs. As deficiency deepens, the dorsal and lateral columns of the spinal cord become involved, producing the syndrome known as subacute combined degeneration.

• Peripheral neuropathy — tingling, numbness, or burning in the extremities, often starting in the feet
• Subacute combined degeneration (SCD) — dorsal column and corticospinal tract involvement causing gait ataxia, weakness, and Lhermitte's sign (an electric shock sensation down the spine with neck flexion)
• Cognitive impairment — memory problems, difficulty concentrating, and mental slowing often described as brain fog
• Psychiatric symptoms — depression, irritability, paranoia, or frank psychosis in severe cases
• Glossitis — reddening and loss of the tongue's normal papillae, producing a smooth, painful surface
• Optic neuropathy — reduced visual acuity or color vision changes in rare presentations

The psychiatric symptoms deserve particular emphasis. The 2026 case report in Frontiers in Psychiatry documents a patient with SCD whose presentation initially mimicked an affective disorder, highlighting what the authors describe as diagnostic pitfalls and clinical red flags. Clinicians who encounter mood or cognitive symptoms — particularly in patients with known risk factors for B12 deficiency — should consider checking B12 levels before anchoring on a primary psychiatric diagnosis. A pediatric case series published in 2026 in Frontiers in Nutrition further illustrates that B12 deficiency neurological presentations can appear across the full lifespan, including in infants and young children whose mothers had inadequate B12 status.

Image: File:VitB12DefFull.jpg — Chiara Briani et al. (CC BY-SA 3.0), via Wikimedia Commons

Who Is at Highest Risk

Understanding risk factors is the foundation of earlier diagnosis. B12 is found almost exclusively in animal products — meat, fish, eggs, and dairy — making dietary restriction the leading cause of deficiency in younger adults. But dietary intake alone does not tell the whole story. The body's ability to absorb B12 depends on a protein called intrinsic factor, secreted by the stomach's parietal cells. When this system fails — due to pernicious anemia, gastric surgery, atrophic gastritis, or long-term use of proton pump inhibitors (PPIs) or metformin — deficiency develops even in people eating meat regularly.

Age is an independent risk factor. Reduced stomach acid secretion in older adults impairs the release of B12 from food proteins, even when total dietary intake appears adequate. This means that meat-eating seniors can develop deficiency not because they eat too little B12, but because their GI tract can no longer extract it from food efficiently.

A 2026 multicenter retrospective case series and systematic review published in European Journal of Pediatrics highlights a third, emerging risk group: adolescents who use nitrous oxide recreationally. Nitrous oxide irreversibly inactivates B12 by oxidizing its cobalt ion, and the study documents cases of serious myeloneuropathy — damage to both the spinal cord and peripheral nerves — following recreational use. Unlike chronic dietary depletion, this mechanism can operate acutely: a heavy exposure can precipitate neurological injury in someone whose stores are already marginally low.

Getting the Diagnosis Right

Serum B12 is the appropriate first test, but its limitations matter in practice. When clinical suspicion is high despite a borderline result, two functional biomarkers add clarity:

• Methylmalonic acid (MMA) — elevated specifically in functional B12 deficiency; more sensitive and specific than serum B12 alone, because MMA accumulates when B12-dependent metabolic steps stall
• Homocysteine — elevated in both B12 and folate deficiency; a useful screening marker but less specific to B12 alone

Neuroimaging can confirm suspected SCD. MRI of the spine characteristically shows T2 hyperintensity in the posterior columns — sometimes described as the inverted-V sign in axial sections — in established or severe cases. Electromyography and nerve conduction studies can document peripheral nerve involvement quantitatively.

Treatment: Matching the Approach to Cause and Severity

Once deficiency is confirmed, treatment must address both the underlying cause and the degree of neurological involvement. For mild deficiency without malabsorption, high-dose oral B12 — typically 1000 to 2000 micrograms daily — can be effective. A small fraction of B12, roughly 1% of ingested dose, is absorbed passively through the gut lining without requiring intrinsic factor. At sufficiently high doses, this passive route is enough to restore and maintain adequate levels even in people with pernicious anemia or atrophic gastritis, as long as supplementation is taken consistently.

When neurological involvement is present, most clinicians prefer intramuscular (IM) injections to ensure rapid, reliable repletion that bypasses any uncertainty about GI absorption. A common induction schedule involves daily or alternate-day injections for one to two weeks, followed by monthly maintenance. Clinical improvement often begins within days of starting treatment, but full neurological recovery takes weeks to months and may be incomplete when damage was severe or longstanding.

Addressing the root cause is equally important alongside supplementation. Dietary counseling and consistent supplementation are the primary tools for vegans and vegetarians. For those with pernicious anemia, atrophic gastritis, or post-surgical status, lifelong B12 replacement is typically necessary. Reviewing medications matters too: when clinically appropriate, minimizing long-term PPI use or adding B12 monitoring for patients on metformin can prevent ongoing depletion before symptoms appear.

Image: File:Image of the tongue in a B12-deficient patient without a history of gastrectomy.webp — Jihoon Kim, Moon-Jong Kim & Hong-Seop Kho (CC BY 4.0), via Wikimedia Commons

The Nitrous Oxide Warning: An Acute Route to Neurological Injury

The 2026 multicenter case series and systematic review in European Journal of Pediatrics documents an acute pathway to B12 deficiency that is categorically different from chronic dietary depletion. Recreational nitrous oxide — sold in small cartridges or large canisters at social events — is increasingly popular among teenagers and young adults. When inhaled, it irreversibly oxidizes the cobalt ion at the center of B12's structure, rendering existing stores metabolically inactive without depleting serum B12 concentrations proportionally. Standard lab panels may therefore appear less alarming than the functional situation actually is.

The clinical presentation in nitrous oxide-associated cases tends to be rapid: gait instability, limb weakness, or sensory changes appearing within days to weeks of exposure. The systematic review component of the 2026 study confirms this association across multiple documented cases in the literature. Anyone experiencing neurological symptoms after nitrous oxide use — however brief the exposure — should seek medical evaluation and request both serum B12 and MMA testing. Normal serum B12 does not rule out functional deficiency in this context.

Frequently Asked Questions

How long does it take for B12 deficiency to cause neurological damage?

Body stores of B12 are typically large enough to sustain normal function for two to five years after dietary intake stops. However, once stores are significantly depleted, neurological symptoms can develop over months. The exact timeline varies based on individual absorption capacity, diet, and whether medications that impair B12 absorption are involved. Nitrous oxide compresses this timeline dramatically: it can inactivate available B12 acutely, causing neurological injury after relatively brief recreational use in someone with already-marginal stores.

Can neurological damage from B12 deficiency be fully reversed?

It depends on duration and severity. Early-stage peripheral neuropathy and cognitive symptoms often respond well to B12 repletion, with improvement beginning within weeks. Subacute combined degeneration affecting the spinal cord can stabilize and partially improve with prompt treatment, but recovery may be incomplete when treatment was significantly delayed. The window for full neurological recovery narrows the longer deficiency continues unaddressed — which is the core argument for early testing in at-risk individuals rather than waiting for symptoms to accumulate.

At what B12 level should I be concerned, and what test should I ask for?

Clinical laboratories typically flag serum B12 below 200 pg/mL as deficient, but many neurologists and nutrition researchers argue that functional deficiency can occur at levels below 300 pg/mL, particularly in older adults or those with neurological symptoms. If your level falls in the borderline range and you have consistent symptoms, asking your clinician to measure methylmalonic acid (MMA) is a reasonable and clinically supported next step. A clearly elevated MMA — even with borderline-normal serum B12 — strongly supports functional B12 deficiency and justifies starting treatment.

Bottom Line

Vitamin B12 deficiency is not a rare condition, but its neurological presentations are frequently delayed in recognition, sometimes for months or years. The 2026 clinical literature — from case reports of subacute combined degeneration misdiagnosed as psychiatric illness, to multicenter documentation of myeloneuropathy in adolescents using nitrous oxide — reinforces one consistent message: test earlier and treat promptly. If you fall into any higher-risk group — vegan or very-low-animal-product diet, age over 60, GI conditions, long-term PPI or metformin use, or any history of recreational nitrous oxide — we recommend discussing proactive B12 screening with your healthcare provider rather than waiting for symptoms to appear. When neurological symptoms are already present, initiating treatment quickly is not overcaution; the evidence shows clearly that delay narrows the window for full recovery.

Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before making health decisions.